NCT04011826View on ClinicalTrials.gov

The Evaluation of a New Nasal Mask for the Treatment of Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

August 30, 2020

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

Device: Trial nasal mask (F&P)

This trial nasal mask will serve as the participant's primary PAP/BPAP therapy mask for the duration of the trial period (from Visit 2 to Visit 3). For participants taking part in the study extension, they will be using the trial nasal mask as their primary PAP/BPAP therapy mask for 6 months after Visit 3.

Trial Locations (1)

63143

Clayton Sleep Institute, St Louis

All Listed Sponsors
lead

Fisher and Paykel Healthcare

INDUSTRY

NCT04011826 - The Evaluation of a New Nasal Mask for the Treatment of Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter